Parasites, Hosts and Diseases

The Korea Society for Parasitology and Tropical Medicine (대한기생충학·열대의학회)
권호 표지
DOI QR코드

DOI QR Code

Influenza M1 Virus-Like Particles Consisting of Toxoplasma gondii Rhoptry Protein 4

  • Lee, Su-Hwa (Department of Biomedical Science, Graduate School, Kyung Hee University) ;
  • Lee, Dong-Hun (Department of Biomedical Science, Graduate School, Kyung Hee University) ;
  • Piao, Ying (Department of Emergency, Yanbian University Hospital) ;
  • Moon, Eun-Kyung (Department of Medical Zoology, Kyung Hee University School of Medicine) ;
  • Quan, Fu-Shi (Department of Medical Zoology, Kyung Hee University School of Medicine)
  • Received : 2016.12.28
  • Accepted : 2017.03.11
  • Published : 2017.04.30
Download PDF
⟨ Previous Next ⟩

Abstract

Toxoplasma gondii infections occur throughout the world, and efforts are needed to develop various vaccine candidates expressing recombinant protein antigens. In this study, influenza matrix protein (M1) virus-like particles (VLPs) consisting of T. gondii rhoptry antigen 4 (ROP4 protein) were generated using baculovirus (rBV) expression system. Recombinant ROP4 protein with influenza M1 were cloned and expressed in rBV. SF9 insect cells were coinfected with recombinant rBVs expressing T. gondii ROP4 and influenza M1. As the results, influenza M1 VLPs showed spherical shapes, and T. gondii ROP4 protein exhibited as spikes on VLP surface under transmission electron microscopy (TEM). The M1 VLPs resemble virions in morphology and size. We found that M1 VLPs reacted with antibody from T. gondii-infected mice by western blot and ELISA. This study demonstrated that T. gondii ROP4 protein can be expressed on the surface of influenza M1 VLPs and the M1 VLPs containing T. gondii ROP4 reacted with T. gondii-infected sera, indicating the possibility that M1 VLPs could be used as a coating antigen for diagnostic and/or vaccine candidate against T. gondii infection.

Keywords

References

  1. Dubey JP. Toxoplasmosis of Animals and Humans. 2nd ed. Beltsville, Maryland, USA. CRC. 2010.
  2. Robert-Gangneux F, Darde ML. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012; 25: 264-296. https://doi.org/10.1128/CMR.05013-11
  3. Chen J, Xu MJ, Zhou DH, Song HQ, Wang CR, Zhu XQ. Canine and feline parasitic zoonoses in China. Parasit Vectors 2012; 5: 152. https://doi.org/10.1186/1756-3305-5-152
  4. Lee DH, Lee SH, Kim AR, Quan FS. Virus-Like Nanoparticle Vaccine Confers Protection against Toxoplasma gondii. PLoS One 2016; 11: e0161231. https://doi.org/10.1371/journal.pone.0161231
  5. Hill D, Dubey J. Toxoplasma gondii: transmission, diagnosis and prevention. Clin Microbiol Infect 2002; 8: 634-640. https://doi.org/10.1046/j.1469-0691.2002.00485.x
  6. Liu Q, Wang ZD, Huang SY, Zhu XQ. Diagnosis of toxoplasmosis and typing of Toxoplasma gondii. Parasit Vectors 2015; 8: 292. https://doi.org/10.1186/s13071-015-0902-6
  7. Liesenfeld O, Press C, Montoya JG, Gill R, Isaac-Renton JL, Hedman K, Remington JS. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J Clin Microbiol 1997; 35: 174-178.
  8. Wilson M, Remington JS, Clavet C, Varney G, Press C, Ware D. Evaluation of six commercial kits for detection of human immunoglobulin M antibodies to Toxoplasma gondii. The FDA Toxoplasmosis Ad Hoc Working Group. J Clin Microbiol 1997; 35: 3112-3115.
  9. Kotresha D, Noordin R. Recombinant proteins in the diagnosis of toxoplasmosis. APMIS 2010; 118: 529-542.
  10. Lau YL, Fong MY, Mohd Idris M, Ching XT. Cloning and expression of Toxoplasma gondii dense granule antigen 2 (GRA2) gene by Pichia pastoris. Southeast Asian J Trop Med Public Health 2012; 43: 10.
  11. Thiruvengadam G, Init I, Fong MY, Lau, YL. Optimization of the expression of surface antigen SAG1/2 of Toxoplasma gondii in the yeast Pichia pastoris. Trop Biomed 2011; 28: 506-513.
  12. Chang PY, Fong MY, Nissapatorn V, Lau YL. Evaluation of Pichia pastoris-expressed recombinant rhoptry protein 2 of Toxoplasma gondii for its application in diagnosis of toxoplasmosis. Am J Trop Med Hyg 2011; 85: 485-489. https://doi.org/10.4269/ajtmh.2011.11-0351
  13. Wang Z, Ge W, Huang SY, Li J, Zhu XQ, Liu Q. Evaluation of recombinant granule antigens GRA1 and GRA7 for serodiagnosis of Toxoplasma gondii infection in dogs. BMC Vet Res 2014; 10: 158. https://doi.org/10.1186/1746-6148-10-158
  14. Wang Z, Ge W, Li J, Song M, Sun H, Wei F, Liu Q. Production and evaluation of recombinant granule antigen protein GRA7 for serodiagnosis of Toxoplasma gondii infection in cattle. Foodborne Pathog Dis 2014; 11: 734-739. https://doi.org/10.1089/fpd.2014.1749
  15. Lee DH, Kim AR, Lee SH, Quan FS. Cross-protection induced by Toxoplasma gondii virus-like particle vaccine upon intraperitoneal route challenge. Acta Trop 2016; 164: 77-83. https://doi.org/10.1016/j.actatropica.2016.08.025
  16. Counihan NA, Kalanon M, Coppel RL, de Koning-Ward TF. Plasmodium rhoptry proteins: why order is important. Trends Parasitol 2013; 29: 228-236. https://doi.org/10.1016/j.pt.2013.03.003
  17. Dubremetz JF. Rhoptries are major players in Toxoplasma gondii invasion and host cell interaction. Cell Microbiol 2007; 9: 841-848. https://doi.org/10.1111/j.1462-5822.2007.00909.x
  18. Wang PY, Yuan ZG, Petersen E, Li J, Zhang XX, Li XZ, Li HX, Lv ZC, Cheng T, Ren D, Yang GL, Lin RQ, Zhu XQ. Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice. Clin Vaccine Immunol 2012; 19: 1916-1920. https://doi.org/10.1128/CVI.00397-12
  19. Joyce BR, Queener SF, Wek RC, Sullivan WJ Jr. Phosphorylation of eukaryotic initiation factor-$2{\alpha}$ promotes the extracellular survival of obligate intracellular parasite Toxoplasma gondii. Proc Natl Acad Sci USA 2010; 107: 17200-17205. https://doi.org/10.1073/pnas.1007610107
  20. Chen J, Huang S, Li Z, Yuan Z, Zhou D, Petersen E, Zhang N, Zhu X. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Vaccine 2013; 31: 1734-1739. https://doi.org/10.1016/j.vaccine.2013.01.027
  21. Quan FS, Huang C, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007; 81: 3514-3524. https://doi.org/10.1128/JVI.02052-06
  22. Quan FS, Kim YH, Lee SJ, Yi H, Kang SM, Bozja J, Moore ML, Compans RW. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice. J Infect Dis 2011; 204: 987-995. https://doi.org/10.1093/infdis/jir474
  23. Letscher-Bru V, Pfaff AW, Abou-Bacar A, Filisetti D, Antoni E, Villard O, Klein JP, Candolfi E. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect Immun 2003; 71: 6615-6619. https://doi.org/10.1128/IAI.71.11.6615-6619.2003
  24. Dlugonska H. Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis. J Biomed Biotechnol 2008; e632424
  25. Holec-Gasior, L. Toxoplasma gondii recombinant antigens as tools for serodiagnosis of human toxoplasmosis: current status of studies. Clin Vaccine Immunol 2013; 20: 1343-1351. https://doi.org/10.1128/CVI.00117-13
  26. Jongert E, Roberts CW, Gargano N, Forster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 2009; 104: 252-266.
  27. Dziadek B, Gatkowska J, Grzybowski M, Dziadek J, Dzitko K, Dlugonska H. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Exp Parasitol 2012; 131: 133-138. https://doi.org/10.1016/j.exppara.2012.02.026
  28. Dziadek B, Gatkowska J, Brzostek A, Dziadek J, Dzitko K, Dlugonska H. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Exp Parasitol 2009; 123: 81-89. https://doi.org/10.1016/j.exppara.2009.06.002
  29. Gatkowska J, Dziadek B, Brzostek A, Dziadek J, Dzitko K, Dlugonska H. Determination of diagnostic value of Toxoplasma gondii recombinant ROP2 and ROP4 antigens in mouse experimental model. Pol J Microbiol 2010; 59: 137-141. https://doi.org/10.1099/jmm.0.013474-0

Cited by

  1. Virus-Like Particles Expressing Toxoplasma gondii Rhoptry Protein 18 Induces Better Protection Than Rhoptry Protein 4 against T. gondii Infection vol.56, pp.5, 2017, https://doi.org/10.3347/kjp.2018.56.5.429
  2. Previous Infection with Plasmodium berghei Confers Resistance to Toxoplasma gondii Infection in Mice vol.57, pp.2, 2017, https://doi.org/10.3347/kjp.2019.57.2.93
  3. Toxoplasma gondii virus‐like particle vaccination alleviates inflammatory response in the brain upon T gondii infection vol.42, pp.6, 2017, https://doi.org/10.1111/pim.12716
  4. Protective immunity induced by CpG ODN‐adjuvanted virus‐like particles containing Toxoplasma gondii proteins vol.43, pp.1, 2017, https://doi.org/10.1111/pim.12799
  5. Detection of Toxoplasma gondii Infections using Virus-Like Particles Displaying T. gondii ROP4 Antigen vol.59, pp.6, 2017, https://doi.org/10.3347/kjp.2021.59.6.565